Form D · Biotechnology

Kineticos Disruptor Fund IB8, LLC

Raleigh, NC · CIK 0001869888

Offering snapshot reported Jul 15, 2021 · SEC filing

Reported sold
$5.52M
Offering amount: $18.1M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 15, 2021Initial$5,520,000No comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-406358

Source: Form D, filed Jul 15, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

KINETICOS DISRUPTOR FUND IB8, LLC

Investment adviser: KINETICOS LIFE SCIENCES MANAGEMENT LLC

Gross asset value
$10.9M
Beneficial owners
22
ADV minimum commitment
$0

Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator TMF GROUP CARY, North Carolina, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Custodian FIRST CITIZENS BANK RALEIGH, North Carolina, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No
Filing source

Form ADV 2079386 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-8795962175

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nathan Finger Director, Executive
Frank Lis Executive
Shallesh Maingi Director, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
9131 Anson Way Suite 110
Raleigh, NC, 27615